Nasdaq - Delayed Quote USD

Delaware Healthcare Fund (DLRHX)

25.47 -0.11 (-0.43%)
At close: 8:00 PM EDT

Top 10 Holdings (51.75% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 11.60%
AMGN
Amgen Inc. 6.92%
REGN
Regeneron Pharmaceuticals, Inc. 6.32%
UNH
UnitedHealth Group Incorporated 4.81%
MRK
Merck & Co., Inc. 4.81%
ELV
Elevance Health, Inc. 4.05%
PFE
Pfizer Inc. 3.77%
VKTX
Viking Therapeutics, Inc. 3.26%
BSX
Boston Scientific Corporation 3.23%
4519.T
Chugai Pharmaceutical Co., Ltd. 2.97%

Sector Weightings

SectorDLRHX
Healthcare   98.60%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.38%
Stocks 99.62%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average DLRHX Category Average
Price/Earnings 0.04 24.55
Price/Book 0.27 5.28
Price/Sales 0.36 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 55,572.24 34,862.81
3 Year Earnings Growth -3.65 32.48

Bond Holdings

Performance & Risk

YTD Return 5.33%
5y Average Return 8.82%
Rank in Category (ytd) 12
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.61
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Delaware Funds by Macquarie
Net Assets 791.4M
YTD Return 11.12%
Yield 0.31%
Morningstar Rating
Inception Date Sep 28, 2007

Fund Summary

Under normal circumstances, the fund will invest at least 80% of its assets, plus the amount of any borrowings for investment purposes, in the equity securities of healthcare companies, meaning companies that develop, produce, or distribute products or services related to the healthcare or medical industries and derive a substantial portion, that is, more than 50%, of their sales from products and services in the healthcare industry (80% policy). It is non-diversified.

Related Tickers